SBIO Among Health Care ETFs
End-of-day Nov 13, 2026 · 33 Health care ETFs by YTD
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.5% | −0.3% | +6.5% | −18.0% | +8.6% | +20.4% | +130.5% | +19.2% | +143.2% |
| Peer average | −0.1% | +0.8% | +3.7% | +4.0% | +21.5% | +25.9% | +71.5% | +27.0% | — |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$45 of every $1,000 in SBIO is Oruka
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ORKAOruka Therapeutics | Healthcare | 4.54% | $454.47 | 81K | $8.5M |
| 2 | CGONCG oncology | Healthcare | 4.06% | $406.24 | 108K | $7.6M |
| 3 | MANEVeraDermics | Healthcare | 3.70% | $369.89 | 51K | $6.9M |
| 4 | DNTHDianthus Therapeutics | Healthcare | 3.38% | $338.39 | 68K | $6.3M |
| 5 | EWTXEdgewise Therapeutics | Healthcare | 3.25% | $325.11 | 133K | $6.1M |
| 6 | TVTXTravere Therapeutics | Healthcare | 3.17% | $317.25 | 115K | $5.9M |
| 7 | DFTXDefinium Therapeutics | Healthcare | 2.90% | $289.63 | 164K | $5.4M |
| 8 | XENEXenon Pharmaceuticals | Healthcare | 2.60% | $259.77 | 119K | $4.9M |
| 9 | RLAYRelay Therapeutics | Healthcare | 2.59% | $259.27 | 268K | $4.9M |
| 10 | AMLXAmylyx Pharmaceuticals | Healthcare | 2.45% | $245.29 | 154K | $4.6M |
| 11 | VRDNViridian Therapeutics | Healthcare | 2.26% | $225.94 | 139K | $4.2M |
| 12 | TARSTarsus Pharmaceuticals | Healthcare | 2.21% | $220.76 | 54K | $4.1M |
| 13 | IRONDisc Medicine | Healthcare | 2.09% | $209.06 | 47K | $3.9M |
| 14 | DYNDyne Therapeutics | Healthcare | 2.08% | $207.87 | 229K | $3.9M |
| 15 | ACADACADIA Pharmaceuticals | Healthcare | 2.04% | $204.09 | 210K | $3.8M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ORKA | Oruka Therapeutics | 4.54% |
| 2 | CGON | CG oncology | 4.06% |
| 3 | MANE | VeraDermics | 3.70% |
| 4 | DNTH | Dianthus Therapeutics | 3.38% |
| 5 | EWTX | Edgewise Therapeutics | 3.25% |
| 6 | TVTX | Travere Therapeutics | 3.17% |
| 7 | DFTX | Definium Therapeutics | 2.90% |
| 8 | XENE | Xenon Pharmaceuticals | 2.60% |
| 9 | RLAY | Relay Therapeutics | 2.59% |
| 10 | AMLX | Amylyx Pharmaceuticals | 2.45% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 19, 2024 | Dec 26, 2024 | $1.17 |
| Dec 21, 2023 | Dec 27, 2023 | $0.0711 |
| Dec 19, 2019 | Dec 27, 2019 | $0.0160 |
| Dec 20, 2018 | Dec 27, 2018 | $0.78 |
| Dec 21, 2017 | Dec 28, 2017 | $0.58 |